Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDeferred TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Cash from Financing Activities (2019 - 2026)

Sanofi's Cash from Financing Activities history spans 6 years, with the latest figure at -$1.8 billion for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 187.09% to -$1.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$22.3 billion, a 234.57% decrease, with the full-year FY2025 number at -$9.5 billion, down 54.22% from a year prior.
  • Cash from Financing Activities hit -$1.8 billion in Q1 2026 for Sanofi, up from -$9.6 billion in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SNY hit a ceiling of $825.6 million in Q1 2024 and a floor of -$9.6 billion in Q4 2025.
  • Historically, Cash from Financing Activities has averaged -$3.6 billion across 3 years, with a median of -$3.1 billion in 2026.
  • The widest YoY moves for Cash from Financing Activities: up 55.13% in 2025, down 510.48% in 2025.
  • Tracing SNY's Cash from Financing Activities over 3 years: stood at -$6.2 billion in 2024, then crashed by 55.13% to -$9.6 billion in 2025, then surged by 81.29% to -$1.8 billion in 2026.
  • Business Quant data shows Cash from Financing Activities for SNY at -$1.8 billion in Q1 2026, -$9.6 billion in Q4 2025, and -$6.6 billion in Q3 2025.